Disease / condition

NSCLC clinical trials

Free access to 296 studies·10+ countries·Updated daily102 recruiting
296
Total trials
10+
Countries
10+
Sponsors
102
Recruiting
By phase
N/A93
Phase 276
Phase 132
Phase 331
Early Phase 124
By status
Recruiting102
Completed70
Not yet recruit...65
Unknown35
Terminated9
Top countries
China144
Japan16
United States of America11
Netherlands10
South Korea10
Top sponsors
AstraZeneca7
Shanghai Chest Hos...6
Novartis Pharma Se...5
The Netherlands Ca...5
Allist Pharmaceuti...4
Recent trials
Latest clinical trials for NSCLC
NCT06414915·Phase 2Not yet recr...
Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation
National Cancer Center, China
NCT06361927·Phase 2Recruiting
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients
Sunshine Guojian Pharmaceutica...China
NCT06362980·Phase 1Not yet recr...
A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
National Cancer Center, China
NCT06339242·Phase 2Recruiting
A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis
Jiangsu Province Nanjing Brain...China
NCT06329648Not yet recr...
Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer
The Netherlands Cancer Institu...
NCT06328049·Phase 2Recruiting
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
Taixing People's HospitalChina
NCT06332300·Phase 2Recruiting
An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC
Jiangsu Province Nanjing Brain...China
NCT06332287·Phase 2Recruiting
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis
Jiangsu Province Nanjing Brain...China
NCT06317558Recruiting
Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
Cancer Institute and Hospital,...China
NCT06315686·Phase 2Recruiting
The Dynamic Monitoring of Cerebrospinal Fluid ctDNA
Jiangsu Province Nanjing Brain...China
NCT06246110·Phase 2Recruiting
A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer
Eikon TherapeuticsUnited States of America
NCT06247280Recruiting
Korean Registry of Non-Small Cell Lung Cancer Patients With EGFR Mutation
Yuhan CorporationSouth Korea
NCT06255951·Phase 1Recruiting
Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects
TYK Medicines, IncChina
NCT06221670·Phase 2Not yet recr...
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK)
Tianjin Medical University Can...
NCT06218069·Phase 2/3Not yet recr...
Immuno-pet iMaging resPonses administeRed Immune checkpoiNt inhibiTor
Radboud University Medical Cen...Germany,Netherlands
NCT06108726·Phase 2Recruiting
A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer
Northern Jiangsu Province Peop...China
UMIN000052558Not yet recr...
Progression-free, disease-free, and recurrence-free survivals as surrogate in NSCLC perioperative chemotherapy trials
Yokohama City University Hospi...Japan
NCT06094296·Phase 2Not yet recr...
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers SquibbArgentina,Chile,Italy,Poland,Romania,United States of America
NCT06097962·Phase 1Recruiting
Safety and Efficacy of NK510 to Treat NSCLC
Base Therapeutics (Shanghai) C...China
NCT06050278Recruiting
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens
University of Milano BicoccaItaly
About this record

Access comprehensive clinical trial information for NSCLC through Pure Global AI's free database. This collection includes 296 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 102 trials are actively recruiting participants.

Research for NSCLC is being conducted in China, Japan, United States of America and 7+ other countries. Leading sponsors include AstraZeneca and Shanghai Chest Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 296 clinical trials studying NSCLC, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include AstraZeneca, Shanghai Chest Hospital, Novartis Pharma Services Inc., among others.